- Home
- SPH vs SILK Comparison
SPH vs SILK Comparison
Compare SPH & SILK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- SILK
- Stock Information
- Founded
- SPH 1945
- SILK 2007
- Country
- SPH United States
- SILK United States
- Employees
- SPH N/A
- SILK N/A
- Industry
- SPH Other Specialty Stores
- SILK Medical/Dental Instruments
- Sector
- SPH Consumer Discretionary
- SILK Health Care
- Exchange
- SPH Nasdaq
- SILK Nasdaq
- Market Cap
- SPH 1.1B
- SILK 1.1B
- IPO Year
- SPH 1996
- SILK 2019
- Fundamental
- Price
- SPH $17.93
- SILK $27.50
- Analyst Decision
- SPH Hold
- SILK Sell
- Analyst Count
- SPH 3
- SILK 9
- Target Price
- SPH $19.67
- SILK $19.67
- AVG Volume (30 Days)
- SPH 155.1K
- SILK 1.2M
- Earning Date
- SPH 08-08-2024
- SILK 11-06-2024
- Dividend Yield
- SPH 7.28%
- SILK N/A
- EPS Growth
- SPH 7.41
- SILK N/A
- EPS
- SPH 1.51
- SILK N/A
- Revenue
- SPH $1,345,126,000.00
- SILK $191,431,000.00
- Revenue This Year
- SPH N/A
- SILK $15.16
- Revenue Next Year
- SPH N/A
- SILK $11.17
- P/E Ratio
- SPH $11.86
- SILK N/A
- Revenue Growth
- SPH N/A
- SILK 17.53
- 52 Week Low
- SPH $14.57
- SILK $6.08
- 52 Week High
- SPH $22.33
- SILK $27.50
- Technical
- Relative Strength Index (RSI)
- SPH 51.59
- SILK 72.05
- Support Level
- SPH $17.50
- SILK $27.00
- Resistance Level
- SPH $18.28
- SILK $27.17
- Average True Range (ATR)
- SPH 0.43
- SILK 0.08
- MACD
- SPH 0.06
- SILK 0.02
- Stochastic Oscillator
- SPH 59.13
- SILK 98.00
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About SILK Silk Road Medical Inc.
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.